These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Structure, Function, Involvement in Diseases and Targeting of 14-3-3 Proteins: An Update. Cau Y; Valensin D; Mori M; Draghi S; Botta M Curr Med Chem; 2018; 25(1):5-21. PubMed ID: 28462702 [TBL] [Abstract][Full Text] [Related]
5. Small-Molecule Stabilization of the 14-3-3/Gab2 Protein-Protein Interaction (PPI) Interface. Bier D; Bartel M; Sies K; Halbach S; Higuchi Y; Haranosono Y; Brummer T; Kato N; Ottmann C ChemMedChem; 2016 Apr; 11(8):911-8. PubMed ID: 26644359 [TBL] [Abstract][Full Text] [Related]
6. Rational Design, Binding Studies, and Crystal-Structure Evaluation of the First Ligand Targeting the Dimerization Interface of the 14-3-3ζ Adapter Protein. Ehlers M; Grad JN; Mittal S; Bier D; Mertel M; Ohl L; Bartel M; Briels J; Heimann M; Ottmann C; Sanchez-Garcia E; Hoffmann D; Schmuck C Chembiochem; 2018 Mar; 19(6):591-595. PubMed ID: 29282826 [TBL] [Abstract][Full Text] [Related]
7. Discovery of 14-3-3 protein-protein interaction inhibitors that sensitize multidrug-resistant cancer cells to doxorubicin and the Akt inhibitor GSK690693. Mori M; Vignaroli G; Cau Y; Dinić J; Hill R; Rossi M; Colecchia D; Pešić M; Link W; Chiariello M; Ottmann C; Botta M ChemMedChem; 2014 May; 9(5):973-83. PubMed ID: 24715717 [TBL] [Abstract][Full Text] [Related]
8. Stabilization and inhibition of protein-protein interactions: the 14-3-3 case study. Milroy LG; Brunsveld L; Ottmann C ACS Chem Biol; 2013 Jan; 8(1):27-35. PubMed ID: 23210482 [TBL] [Abstract][Full Text] [Related]
9. Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3σ case. Corradi V; Mancini M; Santucci MA; Carlomagno T; Sanfelice D; Mori M; Vignaroli G; Falchi F; Manetti F; Radi M; Botta M Bioorg Med Chem Lett; 2011 Nov; 21(22):6867-71. PubMed ID: 21962576 [TBL] [Abstract][Full Text] [Related]
10. Modulators of 14-3-3 Protein-Protein Interactions. Stevers LM; Sijbesma E; Botta M; MacKintosh C; Obsil T; Landrieu I; Cau Y; Wilson AJ; Karawajczyk A; Eickhoff J; Davis J; Hann M; O'Mahony G; Doveston RG; Brunsveld L; Ottmann C J Med Chem; 2018 May; 61(9):3755-3778. PubMed ID: 28968506 [TBL] [Abstract][Full Text] [Related]
11. Discovery of a Plant 14-3-3 Inhibitor Possessing Isoform Selectivity and In Planta Activity. Nishiyama K; Aihara Y; Suzuki T; Takahashi K; Kinoshita T; Dohmae N; Sato A; Hagihara S Angew Chem Int Ed Engl; 2024 Jul; 63(27):e202400218. PubMed ID: 38658314 [TBL] [Abstract][Full Text] [Related]
12. Polypharmacological Perturbation of the 14-3-3 Adaptor Protein Interactome Stimulates Neurite Outgrowth. Kaplan A; Andrei SA; van Regteren Altena A; Simas T; Banerjee SL; Kato N; Bisson N; Higuchi Y; Ottmann C; Fournier AE Cell Chem Biol; 2020 Jun; 27(6):657-667.e6. PubMed ID: 32220335 [TBL] [Abstract][Full Text] [Related]
13. Identification of the first non-peptidic small molecule inhibitor of the c-Abl/14-3-3 protein-protein interactions able to drive sensitive and Imatinib-resistant leukemia cells to apoptosis. Corradi V; Mancini M; Manetti F; Petta S; Santucci MA; Botta M Bioorg Med Chem Lett; 2010 Oct; 20(20):6133-7. PubMed ID: 20832303 [TBL] [Abstract][Full Text] [Related]
14. Structural aspects of small-molecule inhibition of methyllysine reader proteins. Milosevich N; Warmerdam Z; Hof F Future Med Chem; 2016 Sep; 8(13):1681-702. PubMed ID: 27577975 [TBL] [Abstract][Full Text] [Related]
15. Emerging Therapeutic Potential of SIRT6 Modulators. Fiorentino F; Mai A; Rotili D J Med Chem; 2021 Jul; 64(14):9732-9758. PubMed ID: 34213345 [TBL] [Abstract][Full Text] [Related]
16. 14-3-3 Protein-Protein Interactions: From Mechanistic Understanding to Their Small-Molecule Stabilization. Somsen BA; Cossar PJ; Arkin MR; Brunsveld L; Ottmann C Chembiochem; 2024 Jul; 25(14):e202400214. PubMed ID: 38738787 [TBL] [Abstract][Full Text] [Related]
17. Small molecules modulation of 14-3-3 protein-protein interactions. Mori M; Vignaroli G; Botta M Drug Discov Today Technol; 2013 Dec; 10(4):e541-7. PubMed ID: 24451646 [TBL] [Abstract][Full Text] [Related]
18. Protein-protein interactions as drug targets. Skwarczynska M; Ottmann C Future Med Chem; 2015; 7(16):2195-219. PubMed ID: 26510391 [TBL] [Abstract][Full Text] [Related]
19. Hot spot-based design of small-molecule inhibitors for protein-protein interactions. Guo W; Wisniewski JA; Ji H Bioorg Med Chem Lett; 2014 Jun; 24(11):2546-54. PubMed ID: 24751445 [TBL] [Abstract][Full Text] [Related]
20. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery? Thiel P; Kaiser M; Ottmann C Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]